DIA会员及用户请点击登录

登录

忘记用户 ID? or 忘记密码?

Not a Member?

创建账户并加入。

The Lalit New Delhi

2016 年 11 月 14 日 1:00 下午 - 2016 年 11 月 17 日 6:00 下午

Barakhamba Avenue , Connaught Place, New Delhi 110001, India

5th Global Animal Health Conference 2016

Improved Market Access for Authorised Veterinary Medicines – The Asian Perspective

SESSION 2: LEGISLATION AND GUIDANCE

Session Chair(s)

Ken  Noda, PhD

Ken Noda, PhD

Executive Research Officer for Biotech / Regenerative Medicine

Ministry of Agriculture, Forestry and Fisheries Government of Japan, Japan

Atsushi  Yamamoto

Atsushi Yamamoto

Planning and Coordination Division, Evaluation and Organization Section

JMAFF, Japan

Jean-Pierre  Orand, DVM, MPH

Jean-Pierre Orand, DVM, MPH

Director

ANMV (french Agency For Veterinary Medicinal Products) Anses (french Agency Fo, France

SESSION 2: LEGISLATION AND GUIDANCE

Speaker(s)

Ken  Noda, PhD

Legislation: the Law, its Development, Implementation and Revision; the Difference Between Regulations and Guidelines

Ken Noda, PhD

Ministry of Agriculture, Forestry and Fisheries Government of Japan, Japan

Executive Research Officer for Biotech / Regenerative Medicine

Ken  Noda, PhD

International Standards: Codes and Guidelines; What is their Relation with Regional or National Guidelines?

Ken Noda, PhD

Ministry of Agriculture, Forestry and Fisheries Government of Japan, Japan

Executive Research Officer for Biotech / Regenerative Medicine

Ken  Noda, PhD

Other Guidance and Pharmacopoeia: Where can they be Found? What can they Provide?

Ken Noda, PhD

Ministry of Agriculture, Forestry and Fisheries Government of Japan, Japan

Executive Research Officer for Biotech / Regenerative Medicine

Ken  Noda, PhD

Preparing Guidelines; Flexibility Versus Clarity; Public Consultation Process; Access to Scientific Advice; How is Animal Welfare Protected (3Rs)?

Ken Noda, PhD

Ministry of Agriculture, Forestry and Fisheries Government of Japan, Japan

Executive Research Officer for Biotech / Regenerative Medicine

获得信息并保持参与

不要错失任何机会——请加入我们的邮件列表,了解DIA的观点和事件。